Αποτελέσματα Αναζήτησης
Since 1996, Cardinal Partners has been investing in disruptive healthcare technology-enabled services and life sciences companies providing top quartile returns.
- Team
The operating and investment backgrounds of the Cardinal’s...
- Companies
Cardinal Partners is lead investor, raising capital and IPO...
- Our Vision
The transition from paper to digital combined with machine...
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John Clarke has a 35 year record of early-stage venture...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Thomas McKinley has over 35 years of venture capital investment experience with a successful track record of helping entrepreneurs create significant and successful enterprises. Tom joined Cardinal Partners as an advisor in 2008 and since January 2009 has served as a General Partner of the firm.
John Clarke has a 35 year record of early-stage venture capital investment success. John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm. John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.
Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies | Cardinal Partners has extensive experience in starting, incubating and investing...
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
John Clarke has a 35 year record of early-stage venture capital investment success. John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm. John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.
John Clarke has a 35 year record of early-stage venture capital investment success. John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm. John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.